Pulmonary Sarcoidosis following DB00005 Treatment . Tumour necrosis factor ( P01375 ) is an important cytokine involved in the pathology of a number of inflammatory conditions , and thus blockade with anti- P01375 therapies is becoming the cornerstone in managing such diseases . With increasing use , evidence is collected for the association of sarcoid-like granulomatous disease developing after the initiation of anti- P01375 -Î± therapy , with disease reversal after discontinuation .